Synergic silencing of costimulatory molecules prevents cardiac allograft rejection

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Zhang, Xusheng ^a,b   Liu, Yanling ^c   Zhang, Guangfeng ^a,d   Shi, Jun ^c   Zhang, Xiao ^d   Zheng, Xiufen ^a   Jiang, Alex T ^a   Zhang, Zhu Xu ^a,b   Johnston, Nathan ^a   Siu, King S ^a   Chen, Ruiqi ^a   Lian, Dameng ^b   Koos, David ^e   Quan, Douglas ^a,b   Min, Wei Ping ^a,b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c NANCHANG UNIVERSITY   (China)

^d GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^e Regen BioPharma Inc   (United States)

Author keywords

Co stimulatory molecule; Heart transplantation; RNA interference; Tolerance

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXP3; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GROUP TYPING; BLOOD VESSEL OCCLUSION; CARDIAC GRAFT REJECTION; CD4+ CD25+ T LYMPHOCYTE; CD40 GENE; CD80 GENE; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; EDEMA; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE SILENCING; GENE TARGETING; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART FUNCTION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; RNA INTERFERENCE; SHAM PROCEDURE; SPLEEN; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; GENETICS; GRAFT REJECTION; HEART TRANSPLANTATION; MIXED LYMPHOCYTE CULTURE; NUCLEOTIDE SEQUENCE; VALIDATION STUDY;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD80; BASE SEQUENCE; DNA PRIMERS; FLOW CYTOMETRY; GENE SILENCING; GRAFT REJECTION; HEART TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 84901586846     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-142     Document Type: Article

References (45)

1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811. 10.1146/annurev.immunol.18.1.767, 10837075.
2. Reise Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 2006, 6:476-483. 10.1038/nri1845, 16691244.
3. Thomson AW, Robbins PD. Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann Rheum Dis 2008, 67(Suppl 3):iii90-iii96.
4. Wang Q, Zhang M, Ding G, Liu Y, Sun Y, Wang J, Zhang W, Fu Z, Cao X. Anti-ICAM-1 antibody and CTLA-4Ig synergistically enhance immature dendritic cells to induce donor-specific immune tolerance in vivo. Immunol Lett 2003, 90:33-42. 10.1016/S0165-2478(03)00160-3, 14611905.
5. Beriou G, Moreau A, Cuturi MC. Tolerogenic dendritic cells: applications for solid organ transplantation. Curr Opin Organ Transplant 2012, 17:42-47. 10.1097/MOT.0b013e32834ee662, 22227722.
6. Magee CN, Boenisch O, Najafian N. The role of costimulatory molecules in directing the functional differentiation of alloreactive T helper cells. Am J Transplant 2012, 12:2588-2600. 10.1111/j.1600-6143.2012.04180.x, 3459149, 22759274.
7. McGrath MM, Najafian N. The role of coinhibitory signaling pathways in transplantation and tolerance. Front Immunol 2012, 3:47. 3342378, 22566929.
8. Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001, 19:225-252. 10.1146/annurev.immunol.19.1.225, 11244036.
9. Wojciechowski D, Vincenti F. Challenges and opportunities in targeting the costimulation pathway in solid organ transplantation. Semin Immunol 2011, 23:157-164. 10.1016/j.smim.2011.07.002, 21856169.
10. Grewal IS, Flavell RA. A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol Today 1996, 17:410-414. 10.1016/0167-5699(96)10030-X, 8854557.
11. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996, 184:747-752. 10.1084/jem.184.2.747, 2192696, 8760829.
12. Vincenti F. Costimulation blockade in autoimmunity and transplantation. J Allergy Clin Immunol 2008, 121:299-306. quiz 307-298, 10.1016/j.jaci.2008.01.002, 18269922.
13. Ferrer IR, Wagener ME, Song M, Kirk AD, Larsen CP, Ford ML. Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade. Proc Natl Acad Sci U S A 2011, 108:20701-20706. 10.1073/pnas.1105500108, 3251074, 22143783.
14. Wang XH, Ding XM, Li Y, Liu HB, Xue WJ, Tian XH, Feng XS, Jiao FM, Zheng J. Simultaneous blockade of the CD40/CD40L and NF-kappaB pathways prolonged islet allograft survival. Transpl Int 2012, 25:118-126. 10.1111/j.1432-2277.2011.01374.x, 22017688.
15. Snanoudj R, de Preneuf H, Creput C, Arzouk N, Deroure B, Beaudreuil S, Durrbach A, Charpentier B. Costimulation blockade and its possible future use in clinical transplantation. Transpl Int 2006, 19:693-704. 10.1111/j.1432-2277.2006.00332.x, 16918529.
16. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498. 10.1038/35078107, 11373684.
17. Hill JA, Ichim TE, Kusznieruk KP, Li M, Huang X, Yan X, Zhong R, Cairns E, Bell DA, Min WP. Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA. J Immunol 2003, 171:691-696. 10.4049/jimmunol.171.2.691, 12847235.
18. de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 2007, 6:443-453. 10.1038/nrd2310, 17541417.
19. Jiang N, Zhang X, Zheng X, Chen D, Siu K, Wang H, Ichim TE, Quan D, McAlister V, Chen G, Min WP. A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis. PLoS One 2012, 7:e44138. 10.1371/journal.pone.0044138, 3435394, 22970170.
20. Jiang N, Zhang X, Zheng X, Chen D, Zhang Y, Siu LK, Xin HB, Li R, Zhao H, Riordan N, Ichim TE, Quan D, Jevnikar AM, Chen G, Min WP. Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury. Am J Transplant 2011, 11:1835-1844. 10.1111/j.1600-6143.2011.03660.x, 21794086.
21. Li R, Zheng X, Popov I, Zhang X, Wang H, Suzuki M, Necochea-Campion RD, French PW, Chen D, Siu L, Koos D, Inman RD, Min WP. Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis. J Transl Med 2012, 10:19. 10.1186/1479-5876-10-19, 3293054, 22289162.
22. Suzuki M, Zheng X, Zhang X, Zhang ZX, Ichim TE, Sun H, Nakamura Y, Inagaki A, Beduhn M, Shunnar A, Garcia B, Min WP. A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells. J Allergy Clin Immunol 2012, 125:737-743. 743 e731-743 e736.
23. Zhang X, Beduhn M, Zheng X, Lian D, Chen D, Li R, Siu LK, Marleau A, French PW, Ichim TE, Min WP. Induction of alloimmune tolerance in heart transplantation through gene silencing of TLR adaptors. Am J Transplant 2012, 12:2675-2688. 10.1111/j.1600-6143.2012.04196.x, 22823145.
24. Kirk AD, Blair PJ, Tadaki DK, Xu H, Harlan DM. The role of CD154 in organ transplant rejection and acceptance. Philos Trans R Soc Lond B Biol Sci 2001, 356:691-702. 10.1098/rstb.2001.0855, 1088456, 11375072.
25. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Buhlman J, Xu J, Flavell RA, Korngold R, Noelle R, Vallera DA. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J Immunol 1997, 158:29-39.
26. Taylor PA, Friedman TM, Korngold R, Noelle RJ, Blazar BR. Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood 2002, 99:4601-4609. 10.1182/blood.V99.12.4601, 12036894.
27. Li M, Zhang X, Zheng X, Lian D, Zhang ZX, Ge W, Yang J, Vladau C, Suzuki M, Chen D, Zhong R, Garcia B, Jevnikar AM, Min WP. Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference. J Immunol 2007, 178:5480-5487. 10.4049/jimmunol.178.9.5480, 17442929.
28. Zhang X, Zheng X, Sun H, Feng B, Chen G, Vladau C, Li M, Chen D, Suzuki M, Min L, et al. Prevention of renal ischemic injury by silencing the expression of renal caspase 3 and caspase 8. Transplantation 2006, 82:1728-1732. 10.1097/01.tp.0000250764.17636.ba, 17198267.
29. Zheng X, Zhang X, Feng B, Sun H, Suzuki M, Ichim T, Kubo N, Wong A, Min LR, Budohn ME, Garcia B, Jevnikar AM, Min WP. Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury. Am J Pathol 2008, 173:973-980. 10.2353/ajpath.2008.080103, 2543066, 18772341.
30. He Y, Pimenov AA, Nayak JV, Plowey J, Falo LD, Huang L. Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivo. Hum Gene Ther 2000, 11:547-554. 10.1089/10430340050015734, 10724033.
31. Shashidharamurthy R, Machiah D, Bozeman EN, Srivatsan S, Patel J, Cho A, Jacob J, Selvaraj P. Hydrodynamic delivery of plasmid DNA encoding human FcgammaR-Ig dimers blocks immune-complex mediated inflammation in mice. Gene Ther 2012, 19:877-885. 10.1038/gt.2011.175, 3296821, 22113315.
32. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998, 392:245-252. 10.1038/32588, 9521319.
33. Pilat N, Sayegh MH, Wekerle T. Costimulatory pathways in transplantation. Semin Immunol 2011, 23:293-303. 10.1016/j.smim.2011.04.002, 3203219, 21616680.
34. Min WP, Zhou D, Ichim TE, Strejan GH, Xia X, Yang J, Huang X, Garcia B, White D, Dutartre P, Jevnikar AM, Zhong R. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 2003, 170:1304-1312. 10.4049/jimmunol.170.3.1304, 12538690.
35. Kalantari T, Kamali-Sarvestani E, Ciric B, Karimi MH, Kalantari M, Faridar A, Xu H, Rostami A. Generation of immunogenic and tolerogenic clinical-grade dendritic cells. Immunol Res 2011, 51:153-160. 10.1007/s12026-011-8255-5, 3474330, 22105838.
36. Gilson CR, Milas Z, Gangappa S, Hollenbaugh D, Pearson TC, Ford ML, Larsen CP. Anti-CD40 monoclonal antibody synergizes with CTLA4-Ig in promoting long-term graft survival in murine models of transplantation. J Immunol 2009, 183:1625-1635. 10.4049/jimmunol.0900339, 2828346, 19592649.
37. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996, 381:434-438. 10.1038/381434a0, 8632801.
38. Jollow KC, Zimring JC, Sundstrom JB, Ansari AA. CD40 ligation induced phenotypic and functional expression of CD80 by human cardiac microvascular endothelial cells. Transplantation 1999, 68:430-439. 10.1097/00007890-199908150-00016, 10459548.
39. Hino T, Yokota T, Ito S, Nishina K, Kang YS, Mori S, Hori S, Kanda T, Terasaki T, Mizusawa H. In vivo delivery of small interfering RNA targeting brain capillary endothelial cells. Biochem Biophys Res Commun 2006, 340:263-267. 10.1016/j.bbrc.2005.11.173, 16364250.
40. Zheng X, Vladau C, Zhang X, Suzuki M, Ichim TE, Zhang ZX, Li M, Carrier E, Garcia B, Jevnikar AM, Min WP. A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation. Blood 2009, 113:2646-2654. 10.1182/blood-2008-04-151191, 19164600.
41. Hornick PI, Mason PD, Yacoub MH, Rose ML, Batchelor R, Lechler RI. Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans. Circulation 1998, 97:1257-1263. 10.1161/01.CIR.97.13.1257, 9570195.
42. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Cook HT, Lechler RI. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J Immunol 2001, 167:7199-7206. 10.4049/jimmunol.167.12.7199, 11739543.
43. Zheng X, Lian D, Wong A, Bygrave M, Ichim TE, Khoshniat M, Zhang X, Sun H, De Zordo T, Lacefield JC, Garcia B, Jevnikar AM, Min WP. Novel small interfering RNA-containing solution protecting donor organs in heart transplantation. Circulation 2009, 120:1099-1107. 1091 p following 1107, 10.1161/CIRCULATIONAHA.108.787390, 19738144.
44. Sagoo P, Lombardi G, Lechler RI. Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. Front Immunol 2012, 3:184. 3395995, 22811678.
45. Vudattu NK, Herold KC. Delayed anti-CD3 therapy in a mouse heart transplant model induced tolerance and long-term survival of allograft: achieving tolerance. Immunotherapy 2013, 5:1173-1176. 10.2217/imt.13.113, 24188671.